SCHEMBL19126497

SCHEMBL19126497

CC(C)(C)OC(=O)N1CCN(C(=O)Cn2ccc3cc(N=[N+]=[N-])ccc32)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.43
▸ TGFBR1 P36897 1/20 0.42
▸ DTYMK P23919 2/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CHRM1 P11229 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ VEGFA P15692 1/20 0.37
▸ EGLN1 Q9GZT9 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ F2 P00734 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PDE3B Q13370 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ GPR4 P46093 1/20 0.35
▸ RIPK1 Q13546 1/20 0.34
▸ CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19126462 0.83 POLB (0.49) LOXL2TGFBR1DTYMKCHRM2CHRM4
SCHEMBL20676201 0.81 KRAS (0.47) LOXL2DTYMKCHRM2CHRM4CHRM1
SCHEMBL19145537 0.81 LOXL2 (0.47) LOXL2DTYMKCHRM2CHRM4CHRM1
SCHEMBL19126494 0.76 MEN1 (0.48) TGFBR1DTYMKCHRM2CHRM4CHRM1
SCHEMBL19126474 0.75 ATM (0.50) KDM4EALDH1A1
SCHEMBL17782924 0.75 DTYMK (0.66) TGFBR1DTYMKCHRM2CHRM4CHRM1
SCHEMBL19126749 0.74 SIRT3 (0.47) TGFBR1ALDH1A1MEN1KMT2APDE3B
SCHEMBL19126538 0.72 GPR119 (0.44) LOXL2ALDH1A1MEN1GLAKMT2A
SCHEMBL1921265 0.72 MAPT (0.48) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL19126563 0.72 MAPT (0.58) TGFBR1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939314-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2024-03-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
CN-108473485-B Quinolin-2-one derivatives 默克专利股份公司 2021-11-02 — — CN disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
EP-3402792-A1 QUINOLIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-11-21 — — EP disclosed
WO-2017121444-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2017-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174241-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 LOXL2 3240/4885TGFBR1 4192/4885DTYMK 588/4885
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 LOXL2 3240/4885TGFBR1 4192/4885DTYMK 588/4885
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 LOXL2 3240/4885TGFBR1 4192/4885DTYMK 588/4885
US-11939314-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 LOXL2 3240/4885TGFBR1 4192/4885DTYMK 588/4885
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 LOXL2 3240/4885TGFBR1 4192/4885DTYMK 588/4885
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 LOXL2 3240/4885TGFBR1 4192/4885DTYMK 588/4885
US-10669251-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 LOXL2 3240/4885TGFBR1 4192/4885DTYMK 588/4885
US-11186562-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 LOXL2 3240/4885TGFBR1 4192/4885DTYMK 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback